Sinopac Venture Capital adopts an ecosystem strategy to support deal sourcing, promote business collaboration, and establish strategic alliances to enhance the value of portfolio companies. Founded in January 2003, the firm mainly invests in early-stage, growth, and expansion-stage companies in e-commerce, FinTech, Industry 4.0, automation equipment, cultural and creative industries, and biotech/medical devices. With frequent cross-strait exchanges, Sinopac actively seeks partnerships in China to expand its footprint. The firm’s investment strategy allows staged exits to maintain consistent returns. Combining Sinopac Financial Holdings and external partners, the company develops innovative industry investment businesses and provides operational support to portfolio companies. Investments are primarily registered in Taiwan, with some in the Cayman Islands and the U.S.
Sinopac Venture Capital
Active Investor
Update：2025/06/09
Industries
Biotechnology
Manufacturing
Science and Engineering
3D Technology
Advanced Materials
Artificial Intelligence (AI)
Beauty
Bioinformatics
Biotechnology
Clinical Trials
Construction
Digital Health
Education
Genetics
Health Diagnostics
Image Recognition
Industrial
Industrial Manufacturing
Mechanical Engineering
Medical Device
Metal Processing
Optoelectronics
Pharmaceutical
Pollution Control
Recycling
Sustainability
Water Purification
Introduction
Country
Taiwan
Unified Business No.
80352673
Investors Type
Venture Capital
Exclusive content for members
Members-only content. Please log in to access.
NDF Collaborated Investor
No
